Table 3 Patients’ characteristics, surgical technique, and perioperative results for the total cohort, the subgroup with cardiovascular disease (CVD), and the subgroup without cardiovascular conditions (NO)
All patients n = 474 | CVD n = 148 | NO n = 326 | p | |
|---|---|---|---|---|
Age, median (range) | 58 (24) | 70 (18) | 52 (19) | < 0.001 |
Male, n (%) | 388 (81.9%) | 124 (83.8%) | 264 (81%) | 0.463 |
Female, n (%) | 86 (18.1%) | 24 (16.2%) | 62 (19%) | |
ASA, n (%) | < 0.001 | |||
1 | 8 (1.7%) | 1 (0.7%) | 7 (2.2%) | |
2 | 430 (92.1%) | 121 (85.2%) | 309 (95.1%) | |
3 | 29 (6.2%) | 20 (14.1%) | 9 (2.8%) | |
4 | 0 | 0 | 0 | |
5 | 0 | 0 | 0 | |
BMI, mean (range) | 25.3 (16.3–53) | 26.1 (17–53) | 24.9 (16.3–41) | 0.005 |
Antithrombotic treatment | 49 (10.3%) | 49 (33.1%) | 0 | < 0.001 |
Lichtenstein n (%) | 223 (47%) | 102 (68.9%) | 121 (37.1%) | < 0.001 |
TAPP n (%) | 251 (53%) | 46 (31.1%) | 205 (62.9%) | |
Anesthesia | ||||
General, n (%) | 468 (98.7%) | 148 (100%) | 320 (98.2%) | 0.033 |
Regional, n (%) | 6 (1.3%) | 0 | 6 (1.8%) | |
Local | 0 | 0 | 0 | |
Operating time (min), median (range) | 70.9 (20–212) | 69.9 (25–210) | 71.3 (20–212) | 0.544 |
Days of hospital stay, mean (range) | 3 (0–41) | 3 (0–17) | 3 (0–42) | 0.021 |